Cargando…
帕博利珠单抗对晚期非小细胞肺癌患者T淋巴细胞亚群的影响及疗效观测
BACKGROUND AND OBJECTIVE: The aim of this study is to investigate the changes of peripheral blood lymphocyte subsets before and after treatment with pembrolizumab for non-small cell lung cancer and its clinical significance. METHODS: A total of 32 patients with non-small cell lung cancer who receive...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143964/ https://www.ncbi.nlm.nih.gov/pubmed/33819968 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.103.03 |
Ejemplares similares
-
帕博利珠单抗联合安罗替尼四线治疗EGFR基因敏感突变阳性肺腺癌1例
Publicado: (2021) -
贝伐珠单抗在晚期非小细胞肺癌一线治疗中的研究进展
Publicado: (2020) -
晚期肺腺癌患者一线化疗后T淋巴细胞亚群变化及临床意义
Publicado: (2012) -
尼妥珠单抗对不同化疗药物在肺癌PC9细胞中敏感性的影响及其机制
Publicado: (2015) -
奥希替尼联合贝伐珠单抗在获得性EGFR T790M突变晚期非小细胞肺癌的疗效分析
Publicado: (2022)